These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
85 related articles for article (PubMed ID: 159011)
21. The activation mechanism of human plasminogen. Rickli EE Thromb Diath Haemorrh; 1975 Nov; 34(2):386-95. PubMed ID: 128150 [No Abstract] [Full Text] [Related]
22. Evidence for the progressive uptake of anisoylated plasminogen streptokinase activator complex by clots in human plasma in vitro. Fears R; Ferres H; Standring R Drugs; 1987; 33 Suppl 3():51-6. PubMed ID: 2960513 [No Abstract] [Full Text] [Related]
23. Characterization of domain deletion and/or duplication mutants of a recombinant chimera of tissue-type plasminogen activator and urokinase-type plasminogen activator (rt-PA/u-PA). Nelles L; Lijnen HR; Van Nuffelen A; Demarsin E; Collen D Thromb Haemost; 1990 Aug; 64(1):53-60. PubMed ID: 2148847 [TBL] [Abstract][Full Text] [Related]
24. The mechanism of activation of plasminogen at the fibrin surface by tissue-type plasminogen activator in a plasma milieu in vitro. Role of alpha 2-antiplasmin. Rouy D; Anglés-Cano E Biochem J; 1990 Oct; 271(1):51-7. PubMed ID: 1699517 [TBL] [Abstract][Full Text] [Related]
25. Fluorogenic fibrinogen and fibrin facilitate macromolecular assembly and dynamic assay of picomolar levels of plasminogen activators under well mixed conditions. Wu JH; Diamond SL Thromb Haemost; 1995 Aug; 74(2):711-7. PubMed ID: 8585011 [TBL] [Abstract][Full Text] [Related]
26. Actin stimulates plasmin generation by tissue and urokinase-type plasminogen activators. Lind SE; Smith CJ Arch Biochem Biophys; 1993 Nov; 307(1):138-45. PubMed ID: 8239651 [TBL] [Abstract][Full Text] [Related]
27. Plasminogen binding by alpha 2-antiplasmin and histidine-rich glycoprotein does not inhibit plasminogen activation at the surface of fibrin. Angles-Cano E; Rouy D; Lijnen HR Biochim Biophys Acta; 1992 Dec; 1156(1):34-42. PubMed ID: 1472536 [TBL] [Abstract][Full Text] [Related]
28. Tissue-type plasminogen activator (t-PA) and single chain urokinase-type plasminogen activator (scu-PA): potential for fibrin-specific thrombolytic therapy. Collen D Prog Hemost Thromb; 1986; 8():1-18. PubMed ID: 3104986 [No Abstract] [Full Text] [Related]
29. Tissue plasminogen activator (tPA) inhibits plasmin degradation of fibrin. A mechanism that slows tPA-mediated fibrinolysis but does not require alpha 2-antiplasmin or leakage of intrinsic plasminogen. Wu JH; Diamond SL J Clin Invest; 1995 Jun; 95(6):2483-90. PubMed ID: 7769094 [TBL] [Abstract][Full Text] [Related]
30. Identification of molecular forms of plasminogen and plasmin-inhibitor complexes in urokinase-activated human plasma. Müllertz S; Thorsen S; Sottrup-Jensen L Biochem J; 1984 Oct; 223(1):169-77. PubMed ID: 6208893 [TBL] [Abstract][Full Text] [Related]
31. Cleavage of surfactant-incorporating fibrin by different fibrinolytic agents. Kinetics of lysis and rescue of surface activity. Günther A; Markart P; Kalinowski M; Ruppert C; Grimminger F; Seeger W Am J Respir Cell Mol Biol; 1999 Dec; 21(6):738-45. PubMed ID: 10572071 [TBL] [Abstract][Full Text] [Related]
32. Identification of a site in fibrin(ogen) which is involved in the acceleration of plasminogen activation by tissue-type plasminogen activator. Nieuwenhuizen W; Vermond A; Voskuilen M; Traas DW; Verheijen JH Biochim Biophys Acta; 1983 Oct; 748(1):86-92. PubMed ID: 6684481 [TBL] [Abstract][Full Text] [Related]
33. Biochemical properties of recombinant mutants of nonglycosylated single chain urokinase-type plasminogen activator. Li XK; Lijnen HR; Nelles L; Hu MH; Collen D Biochim Biophys Acta; 1992 Sep; 1159(1):37-43. PubMed ID: 1390910 [TBL] [Abstract][Full Text] [Related]
34. A comparison of the plasminogen activator activity units of urinary-type plasminogen activator (u-PA) and tissue-type plasminogen activator (t-PA). Creighton-Kempsford LJ; Pring JB; Gaffney PJ Blood Coagul Fibrinolysis; 1992 Aug; 3(4):481-3. PubMed ID: 1420825 [TBL] [Abstract][Full Text] [Related]
35. Effect of individual caseins on plasminogen activation by bovine urokinase-type and tissue-type plasminogen activators. Politis I; White JH; Zavizion B; Goldberg JJ; Guo MR; Kindstedt P J Dairy Sci; 1995 Mar; 78(3):484-90. PubMed ID: 7782505 [TBL] [Abstract][Full Text] [Related]
36. Autonomous functions of structural domains on human tissue-type plasminogen activator. van Zonneveld AJ; Veerman H; Pannekoek H Proc Natl Acad Sci U S A; 1986 Jul; 83(13):4670-4. PubMed ID: 3088564 [TBL] [Abstract][Full Text] [Related]
37. The interaction of streptokinase.plasminogen activator complex, tissue-type plasminogen activator, urokinase and their acylated derivatives with fibrin and cyanogen bromide digest of fibrinogen. Relationship to fibrinolytic potency in vitro. Cassels R; Fears R; Smith RA Biochem J; 1987 Oct; 247(2):395-400. PubMed ID: 3122725 [TBL] [Abstract][Full Text] [Related]